Shengfeng Huang

Prof. Dr. Shengfeng Huang

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2024 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
XCXiyu Chen
Xiyu Chen
YHYang Huang
Yang Huang
SYShuo Yang
Shuo Yang
SWSheng Wang
Sheng Wang
LCLin Chen
Lin Chen
SHShengfeng Huang
Shengfeng Huang

22 November 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
HSHuikai Shao
Huikai Shao
XHXia He
Xia He
LZLijuan Zhang
Lijuan Zhang
SDShan Du
Shan Du
XYXiaoqing Yi
Xiaoqing Yi
RTRong sheng Tong
Rong sheng Tong
Background: Ligustrazine injection has been widely used as adjunctive therapy in the treatment of acute cerebral infarction (ACI) during the past decades in China, but its clinical efficacy is not yet well confirmed. This study aims to evaluate the efficacy of ligustrazine injection as adjunctive therapy for ACI.Methods: Databases including China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), PubMed, Medline, Google Scholar, Chinese Biomedical Literature Database, Cochrane Library, Embase, Sino-Med, Wanfang Database, and Chinese Science Citation Database were systematically searched for the published randomized controlled trials (RCTs) on ligustrazine injection in the treatment of ACI until November 2020. Meta-analysis was performed on the primary outcome measure (i.e., clinical effective rate) and the secondary outcome measure [i.e., neurological deficit score (NDS), fibrinogen, low shear blood viscosity (LBV), and high shear blood viscosity (HBV)]. The quality of the included RCTs was assessed according to the M scoring system (the refined Jadad scale). Sensitivity analysis and subgroup analysis were conducted according to the methodological quality, years of publication, and sample size.Results: Nineteen RCTs, containing 2022 patients, were included in this study. Meta-analysis indicated that ligustrazine injection combined with Western medicine could achieve a better effect in the treatment of ACI than using Western medicine alone in terms of clinical effective rate (RR = 1.24; 95% CI, 1.19–1.29), NDS (MD = −3.88; 95%CI, −4.51 to −3.61), fibrinogen (MD = −0.59; 95% CI, −0.76 to −0.42), LBV (MD = −2.11; 95% CI, −3.16 to −1.06), and HBV (MD = −0.88; 95% CI, −1.20 to −0.55).Conclusions: This research indicated that ligustrazine injection as adjunctive therapy seemed to be more effective than using western medicine alone in treating ACI. However, more evidence is required to confirm the efficacy of ligustrazine injection due to the low methodological quality of the included RCTs.

20 July 2024 in Analytica Chimica Acta
Verified
Journal Article
Closed access
QLQiwen Liu
Qiwen Liu
YHYang Huang
Yang Huang
SWSheng Wang
Sheng Wang
SYShuo Yang
Shuo Yang
zhengjin jiangzhengjin jiang
zhengjin jiang
SHShengfeng Huang
Shengfeng Huang

23 August 2025 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
ZZZheng Zhao
Zheng Zhao
ZCZhiwei Chen
Zhiwei Chen
JCJacques Crommen
Jacques Crommen
SHShengfeng Huang
Shengfeng Huang
QWQiqin Wang
Qiqin Wang
zhengjin jiangzhengjin jiang
zhengjin jiang
Autoimmune diseases, cancers, and viral infections pose significant global health threats, characterized by chronic pathology, unregulated cellular proliferation, and rapid transmission, respectively, requiring urgent early warning and treatment strategies. Antibodies, primarily classified into autoantibodies and therapeutic antibodies based on their clinical roles, provide essential information and show considerable value in the precise diagnosis and treatment of these serious diseases. Among the technologies utilized in bioanalysis, electrochemical biosensors, with their unique advantages of rapid response, high sensitivity, miniaturization, cost-effectiveness and user-friendly operation, have been developed as a trending technology for precise diagnostic and therapeutic drug monitoring. This review systematically summarizes the relationships and roles of clinically relevant antibodies in autoimmune diseases, cancers, and viral infections, while detailing the composition, strategies, development, and application trends of relevant electrochemical biosensors. Furthermore, it highlights the remaining challenges and opportunities for the advancement and prospects of electrochemical sensors in the context of clinically relevant antibodies.

1 January 2021 in Journal of Chromatography A
Verified
Journal Article
Closed access
RXRongrong Xu
Rongrong Xu
LLLi Lu
Li Lu
LSLingjue Sun
Lingjue Sun
XLXiao Liu
Xiao Liu
YLYutian Lei
Yutian Lei
zhengjin jiangzhengjin jiang
zhengjin jiang

30 June 2025 in Analytical Chemistry
Verified
Journal Article
Closed access
JCJiamei Chen
Jiamei Chen
XHXinwei Hu
Xinwei Hu
YHYang Huang
Yang Huang
CJChengzhi Jin
Chengzhi Jin
XHXujia Hong
Xujia Hong
SHShengfeng Huang
Shengfeng Huang